ArticleFrontiers in medicine2026
Bronchoscopic lesion resection combined with endobronchial instillation as a salvage therapy for a patient with complex aspergilloma complicated by non-tuberculous mycobacterial infection: case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The infection rate of Case presentation: A 66-years-old female was diagnosed with non-tuberculous mycobacterial lung disease complicated by a complex pulmonary aspergilloma involving the posterior segment of the right upper lobe and the dorsal segment of the right lower lobe. Due to scattered lesions and multiple underlying diseases, surgical resection could not be performed. Instead, based on oral low-dose voriconazole systemic antifungal therapy of 100 mg twice daily, four sessions of bronchoscopic lesion resection with biopsy forceps, and endobronchial instillation of liposomal amphotericin B 10 mg were selected. Finally, the aspergilloma disappeared, and the patient's symptoms were relieved. Conclusion: This case report suggests that for patients with complex pulmonary aspergilloma and non-tuberculous mycobacterial lung infection who are ineligible for surgery and cannot tolerate high-dose systemic antifungal therapy, bronchoscopic lesion resection combined with endobronchial instillation therapy may represent a feasible treatment option with potential clinical benefits. It also serves as a reminder to remain vigilant for the occurrence of aspergillosis following non-tuberculous mycobacterial lung disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.